Abstract
The gene encoding transcription factor 7-like 2 (TCF7L2) has been related to type 2 diabetes in multiple ethnic groups. Here, we investigate whether three single nucleotide polymorphisms (SNPs) in the TCF7L2 gene are associated with an impaired proinsulin:insulin ratio. In this study we examined the associations between SNPs rs7901695, rs7903146 and rs12255372 in the TCF7L2 gene and metabolic variables affecting type 2 diabetes in a population-based study of 706 unrelated individuals (47% men and 53% women; aged 35-74 years) from the province of Segovia in central Spain (Castille), including 180 individuals with type 2 diabetes. The minor allele frequency of rs7901695, rs7903146 and rs12255372 was significantly higher in diabetic patients compared with that in non-diabetic individuals. The T (minor) allele of the variant rs7903146 was significantly associated with a greater OR for type 2 diabetes adjusted for age, sex and BMI in logistic regression analysis: OR 1.29 (95% CI 1.06-1.57, p = 0.01). This risk allele was also associated with an increased proinsulin:insulin ratio after OGTT. Similar results were obtained for the other TCF7L2 SNPs. Our results provide further evidence supporting the belief that the TCF7L2 gene is a major determinant of type 2 diabetes risk in Spain, as in other southern European populations. The association with increased proinsulin:insulin ratio after an OGTT suggests that TCF7L2 might be involved in insulin synthesis and processing.
MeSH Terms
Adult
Aged
Blood Pressure
Body Mass Index
Cross-Sectional Studies
Diabetes Mellitus, Type 2/epidemiology,genetics
Ethnicity
Fasting
Female
Genetic Variation
Humans
Insulin/blood
Male
Middle Aged
Polymorphism, Single Nucleotide
Proinsulin/blood
Regression Analysis
Risk Factors
Spain
TCF Transcription Factors/genetics
Transcription Factor 7-Like 2 Protein
Chemicals
Insulin
TCF Transcription Factors
TCF7L2 protein, human
Transcription Factor 7-Like 2 Protein
Proinsulin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
González-Sánchez J L
Department of Internal Medicine II, Hospital Clínico San Carlos, Madrid, Spain.
Martínez-Larrad M T
Zabena C
Pérez-Barba M
Serrano-Ríos M
References (18)
18 references, click to expand
-
Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
J Clin Endocrinol Metab. 1998 Feb;83(2):604-8
PMID: 9467581
-
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution.
Nat Genet. 2007 Feb;39(2):218-25
PMID: 17206141
-
Effects of TCF7L2 polymorphisms on obesity in European populations.
Obesity (Silver Spring). 2008 Feb;16(2):476-82
PMID: 18239663
-
Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
Diabetes. 2007 Aug;56(8):2178-82
PMID: 17519421
-
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
J Clin Invest. 2007 Aug;117(8):2155-63
PMID: 17671651
-
Wnt signaling regulates pancreatic beta cell proliferation.
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6247-52
PMID: 17404238
-
TCF7L2 genetic defect and type 2 diabetes.
Curr Diab Rep. 2008 Apr;8(2):149-55
PMID: 18445358
-
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia. 1985 Jul;28(7):412-9
PMID: 3899825
-
The new type 2 diabetes gene TCF7L2.
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):391-6
PMID: 17563454
-
TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis.
J Mol Med (Berl). 2007 Jul;85(7):777-82
PMID: 17476472
-
Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men.
Diabetes Care. 2004 Jun;27(6):1433-8
PMID: 15161800
-
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
N Engl J Med. 2006 Jul 20;355(3):241-50
PMID: 16855264
-
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
Diabetologia. 2007 Dec;50(12):2443-50
PMID: 17661009
-
The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits.
Annu Rev Genomics Hum Genet. 2003;4:257-91
PMID: 14527304
-
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
Diabetologia. 2008 Apr;51(4):597-601
PMID: 18264689
-
TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.
Diabetes. 2007 Jul;56(7):1943-7
PMID: 17416797
-
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
Nat Genet. 2006 Mar;38(3):320-3
PMID: 16415884
-
Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
Diabetes. 2006 Oct;55(10):2890-5
PMID: 17003358